Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unraveling the Dyslipidemic Landscape in Moyamoya Disease: O x LDL as a Key Biomarker

1 May 2025

Abstract excerpt

AIMS: The pathogenic mechanisms of moyamoya disease (MMD) remain unrecognized. Although genetic predisposition and hemodynamic changes have been focused on, emerging evidence suggests dyslipidemia may also contribute to MMD. Here, we performed a comprehensive analysis of lipid profiles, aiming to elucidate potential mechanisms in MMD. METHODS: In this prospective case-control study, 222 MMD patients and 231...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cerebrovascular and Carotid Artery Diseases
Share to Moyamoya disease diagnosis and treatment
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40365738
DOI: 10.1111/cns.70441

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unraveling the Dyslipidemic Landscape in Moyamoya Disease: O x LDL as a Key BiomarkerPMID 40365738Read ↗

In-depth cerebrovascular lipidomics profiling for discovering novel biomarkers and mechanisms in moyamoya and intracranial atherosclerotic diseaseSemantic proximity Read ↗

Association of Traditional and Novel Lipid Indicators With the Hemorrhagic Phenotype in Adult Moyamoya Disease: Implications for Lipid Risk StratificationSemantic proximity Read ↗

Association of Traditional and Novel Lipid Indicators With the Hemorrhagic Phenotype in Adult Moyamoya Disease: Implications for Phenotype Stratification.Semantic proximity Read ↗

Multiomics and blood-based biomarkers of moyamoya disease: protocol of Moyamoya Omics Atlas (MOYAOMICS)Semantic proximity Read ↗

Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular DiseasesSemantic proximity Read ↗

Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.Semantic proximity Read ↗

The Susceptibility Pathogenesis of Moyamoya Disease.Semantic proximity Read ↗

Identification of the potential role of S1PR1 in adult moyamoya disease based on multiple bioinformatics analysis and experimental verificationSemantic proximity Read ↗

Common genetic polymorphisms in moyamoya and atherosclerotic disease in Europeans.Semantic proximity Read ↗

RNF213-Related Vasculopathy: An Entity with Diverse Phenotypic ExpressionsSemantic proximity Read ↗

A foundation model for mapping the phenomic and genetic landscape of cerebral small vessel disease biomarkersSemantic proximity Read ↗

Identification of diagnostic markers for moyamoya disease by combining bulk RNA-sequencing analysis and machine learningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.